Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus

Modern Rheumatology

Volumn 23, Issue 4, 2013, Pages 765-773

  Furukawa, Makio ^a   Kiyohara, Chikako ^a   Horiuchi, Takahiko ^a   Tsukamoto, Hiroshi ^a   Mitoma, Hiroki ^a   Kimoto, Yasutaka ^a   Uchino, Ayumi ^a   Nakagawa, Misato ^a   Oryoji, Kensuke ^a   Shimoda, Terufumi ^b   Harada, Mine ^c   Akashi, Koichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA NATIONAL HOSPITAL   (Japan)

^c Omuta National Hospital   (Japan)

Author keywords

Japanese; Systemic lupus erythematosus; Vertebral fracture

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; BONE DENSITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOOD INTAKE; HUMAN; JAPANESE; LIFESTYLE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SPINE FRACTURE; SPINE RADIOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; VERTEBRA BODY; VERTEBRA MALFORMATION;

EID: 84880846687     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0735-5     Document Type: Article

References (66)

1. Uramoto KM, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trend in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999;42:46-50.
2. Swaak AJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol. 1996;25(4):233-8.
3. Lane NE. Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2(10):562-9.
4. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford). 2002;41:1095-100.
5. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol. 1997;24:1922-9.
6. Redlich K, Ziegler S, Kiener HP, Spitzauser S, Stohlawetz P, Bernecker P, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:308-10.
7. Bhattoa HP, Bettembuck P, Balogh A, Szitzauer S, Kiss E. Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol. 2002;21:135-41.
8. Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol. 1999;26:1280-4.
9. Uaratanawrong S, Deesomchoke U, Lertmaharit S, Uaratanawrong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2003;30:2365-8.
10. Borba VZC, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus. 2005;14:529.
11. Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;54:2044-50.
12. Almehed K, Hetenyi S, Ohlsson C, Carlsten H, Forsblad-d'Elia H. Prevalence and risk factors of vertebral compression fractures in female SLE patients. Arthritis Res Ther. 2010;12:R153.
13. Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H, Muñoz-Guarneros M, Escárcega RO, Jiménez-hernández M, et al. Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol. 2009;28:579-85.
14. Ramsay-Goldman R, Dunn JE, Huang C-F, Dunlop D, Rairie JE, Fitzgerald S, et al. Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum. 1999;42:882-90.
15. Weistein RS. Glucocorticoid-induced osteoporosis. Rev Endocr Metab Disord. 2001;2:65-73.
16. Canalis E, Bilezikian JP, Angeli A, Giustina A. Prospectives on glucocorticoid-induced osteoporosis. Bone. 2004;34:593-8.
17. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR; the Study of Osteoporotic Fractures Research Group. Prevalent vertebral deformities predict hip and new vertebral deformities but not wrist fractures. J Bone Miner Res. 1999;14:821-8.
18. Hasserius R, Karlsson MK, Nisson BE, Redlund-Johnell I, Johnell O. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Sweden cohort in the European Vertebral Osteoporosis Study. Osteoporos Int. 2003;14:61-8.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum. 1997;40:1725.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from SCr. Nephron. 1976;16:31.
21. Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543-6.
22. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35:630-40.
23. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-48.
24. Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, et al. High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol. 2009;36:1646-52.
25. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD. Fujiwara S, et al. A comparison of hip fracture incidence among native Japanese, Japanese American, and American Caucasians. Am J Epidemiol. 1991;133:801-9.
26. Hagino H, Yamamoto K, Ohshiro H, Nakamura T, Kishimoto H, Nose T. Changing incidence of hip, distal radius, and proximal humerus fracture in Tottori prefecture. Jpn Bine. 1999;24:265-70.
27. Ross RD, Fujiwara S, Huang C, Davis JW, Epstein RS, Wasnich RD, et al. Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol. 1995;24:1171-7.
28. Kobayashi J. On geographical relationship between the chemical nature of river water and death-rate from apoplexy. Berichte des Ohara Instituts fur landwirt-schaftliche Biologie. 1957;11:12-21.
29. Ministry of Health, Labour and Welfare. The report of National Health and Nutrition Survey of Japan. 2008.
30. Tang NL, Liao CD, Ching JK, Suen EW, Chan IH, et al. Sex-specific effect of pirin gene on bone mineral density in a cohort of 4000 Chinese. Bone. 2010;46:543-50.
31. 3 (alfacalcidol) for treatment of postmenopausal bone loss. J Bone Miner Metab. 2006;24(1):11-5.
32. Wu XP, Liao EY, Huang G, Dai RC, Zhang H. A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women. Calcif Tissue Int. 2003;73(2):122-32.
33. Kwok AWL, Leung JCS, Chan AYH, Au BSK, Lau EMC, Yurianto H, et al. Prevalence of vertebral fracture in Asian men and women: comparison between Hong Kong, Thailand, Indonesia and Japan. Public Health. 2012;126:523-31.
34. Ruyssen-Witrand A, Gossec L, Kolta S. Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review. Osteoporos Int. 2007;18:1271-8.
35. Gärdsell P, Johnell O, Nilsson BE. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int. 1989;44:235-42.
36. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-9.
37. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993;8:1227-33.
38. Huang C, Ross PD, Fujiwara S, Davis JW, Epstein RS, Kodama K, et al. Determinant of vertebral fracture prevalence among native Japanese women and women of Japanese descent living in Hawaii. Bone. 1996;18:437-42.
39. LoCasio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani D, et al. Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 1990;8:39-51.
40. Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, et al. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990;5:1211-6.
41. Sambrook P, Birmingham J, Kelly P, Kempler S, Nquyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328:1747-52.
42. Saito JK, Davis JW, Wasnich RD, Ross PD. Users of low-dose glucocorticoids have increased bone loss rates: a longitudinal study. Calcif Tissue Int. 1995;57:115-9.
43. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777-87.
44. Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN. Vertebral fracture risk with log-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med. 2000;160:2917-22.
45. Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving glucocorticoid therapy: a cross-sectional outpatient study. Bone. 2006;39:253-9.
46. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest. 1998;102:274-82.
47. Andrade F, Casciola-Rosen L, Rosen A. Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis North Am. 2000;26:215-27.
48. Klotbuecher CM, Ross PD, Landswan PB, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15:721-39.
49. Clarita V, Odvina JE, Zerwekh D, Sudhaker R, Naim M, Frank A, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Bone Miner Res. 2005;90:1294-301.
50. Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006;296:2027-38.
51. Harnack L, Stang J, Story M. Soft drink consumption among US children and adolescents. J Am Diet Assoc. 1999;99:436-41.
52. Wyshak G, Frisch RE. Carbonated beverages, dietary calcium, the dietary calcium/phosphorus ratio, and bone fractures in girls and boys. J Adolesc Health. 1994;15:210-5.
53. Heaney R, Recker R. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med. 1982;99:46-52.
54. Heaney RP, Rafferty K. Carbonated beverages and urinary calcium excretion. Am J Clin Nutr. 2001;74:343-7.
55. Heaney RP. Effects of caffeine on bone and the calcium economy. Food Chem Toxicol. 2002;40:1263-70, 7.
56. Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr. 1993;123:1611-4.
57. Hallstrom T, Wolk A, Glynn A, Michaelsson K. Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int. 2006;17:1055-64.
58. Barrett-Connor E, Chang J, Edelstein S. Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA. 1994;271:280-3.
59. Harris S, Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr. 1994;60:573-8.
60. Ilich JZ, Brownbill RA, Tamborini L, Crncevic-Orlic Z. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? J Am Coll Nutr. 2002;21:536-44.
61. Bauer D, Browner W, Cauley J, Orwoll E, Scott J, Black D, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657-65.
62. Lloyd T, Schaeffere JM, Walker MA, Demers LM. Urinary hormonal concentrations and spinal bone densities of premenopausal vegetarian and nonvegetarian women. Am J Clin Nutr. 1991;54:1005-10.
63. Barger-Lux MJ, Heaney RP, Stegman MR. Effects of moderate caffeine intake on the calcium economy of premenopausal women. Am J Clin Nutr. 1990;52:722-5.
64. Curatolo PW, Robertson D. The health consequences of caffeine. Ann Intern Med. 1983;98:641-53.
65. Hagarty VH, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr. 2000;71:1003-7.
66. Sakamoto W, Nishihira K, Iizuka T, Handa H, Ozaki M, Yukawa S. Effect of coffee consumption on bone metabolism. Bone. 2001;28:332-6.